207 related articles for article (PubMed ID: 17353665)
21. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
22. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
Alagona P
Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
[TBL] [Abstract][Full Text] [Related]
23. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
Broncel M; Balcerak M; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
[TBL] [Abstract][Full Text] [Related]
24. Statin drug interactions and related adverse reactions.
Bellosta S; Corsini A
Expert Opin Drug Saf; 2012 Nov; 11(6):933-46. PubMed ID: 22866966
[TBL] [Abstract][Full Text] [Related]
25. Monotherapy vs combination therapy for dyslipidemia in the elderly.
Shepherd J
Am J Geriatr Cardiol; 2008; 17(2):108-13. PubMed ID: 18326949
[TBL] [Abstract][Full Text] [Related]
26. [Therapy of dyslipidemia in post-infarction: state of the art].
Borgia MC; Nardi M; Da Ros S; Castellano V
Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719
[TBL] [Abstract][Full Text] [Related]
27. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
Fazio S
Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
[TBL] [Abstract][Full Text] [Related]
28. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Davidson M
Am J Cardiol; 2008 Dec; 102(12A):19L-27L. PubMed ID: 19084086
[TBL] [Abstract][Full Text] [Related]
29. Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin.
Khandwala HM
South Med J; 2006 Dec; 99(12):1385-7. PubMed ID: 17233196
[TBL] [Abstract][Full Text] [Related]
30. Ezetimibe: cholesterol lowering and beyond.
Bays HE; Neff D; Tomassini JE; Tershakovec AM
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
[TBL] [Abstract][Full Text] [Related]
31. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification.
Sang ZC; Wang F; Zhou Q; Li YH; Li YG; Wang HP; Chen SY
Chin Med J (Engl); 2009 Jul; 122(14):1615-20. PubMed ID: 19719960
[TBL] [Abstract][Full Text] [Related]
32. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
[TBL] [Abstract][Full Text] [Related]
33. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
Taylor AJ
Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240
[TBL] [Abstract][Full Text] [Related]
34. Treatment of high-risk older persons with lipid-lowering drug therapy.
Aronow WS
Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628
[TBL] [Abstract][Full Text] [Related]
35. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics, lipid disorders, and treatment options.
Gryn SE; Hegele RA
Clin Pharmacol Ther; 2014 Jul; 96(1):36-47. PubMed ID: 24722394
[TBL] [Abstract][Full Text] [Related]
37. [Statins with a perspective of lifelong therapy].
Ertaş FS
Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
[TBL] [Abstract][Full Text] [Related]
38. [Can cardiovascular events be prevented by raising HDL cholesterol?].
Langslet G; Reikvam A
Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1519-23. PubMed ID: 18587459
[TBL] [Abstract][Full Text] [Related]
39. Influence of statins on MHC class I expression.
Singh P; Kohr D; Kaps M; Blaes F
Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
[TBL] [Abstract][Full Text] [Related]
40. Statin therapy and stroke prevention: what was known, what is new and what is next?
Mazighi M; Lavallée PC; Labreuche J; Amarenco P
Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
